Newron Pharmaceuticals (Switzerland) Market Value
| NWRN Stock | CHF 8.49 0.44 5.47% |
| Symbol | Newron |
Newron Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Newron Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Newron Pharmaceuticals.
| 01/05/2023 |
| 12/25/2024 |
If you would invest 0.00 in Newron Pharmaceuticals on January 5, 2023 and sell it all today you would earn a total of 0.00 from holding Newron Pharmaceuticals SpA or generate 0.0% return on investment in Newron Pharmaceuticals over 720 days. Newron Pharmaceuticals is related to or competes with Santhera Pharmaceuticals, Basilea Pharmaceutica, Evolva Holding, and COSMO Pharmaceuticals. Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manu... More
Newron Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Newron Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Newron Pharmaceuticals SpA upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.77 | |||
| Information Ratio | 0.0426 | |||
| Maximum Drawdown | 28.39 | |||
| Value At Risk | (3.70) | |||
| Potential Upside | 5.78 |
Newron Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Newron Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Newron Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Newron Pharmaceuticals historical prices to predict the future Newron Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0511 | |||
| Jensen Alpha | 0.1993 | |||
| Total Risk Alpha | 0.0314 | |||
| Sortino Ratio | 0.0606 | |||
| Treynor Ratio | 2.08 |
Newron Pharmaceuticals Backtested Returns
Newron Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Newron Pharmaceuticals has Sharpe Ratio of 0.0661, which conveys that the firm had a 0.0661% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Newron Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Newron Pharmaceuticals' Mean Deviation of 2.48, downside deviation of 2.77, and Risk Adjusted Performance of 0.0511 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Newron Pharmaceuticals holds a performance score of 5. The company secures a Beta (Market Risk) of 0.0975, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Newron Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Newron Pharmaceuticals is expected to be smaller as well. Please check Newron Pharmaceuticals' treynor ratio, value at risk, downside variance, as well as the relationship between the maximum drawdown and potential upside , to make a quick decision on whether Newron Pharmaceuticals' current price movements will revert.
Auto-correlation | -0.09 |
Very weak reverse predictability
Newron Pharmaceuticals SpA has very weak reverse predictability. Overlapping area represents the amount of predictability between Newron Pharmaceuticals time series from 5th of January 2023 to 31st of December 2023 and 31st of December 2023 to 25th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Newron Pharmaceuticals price movement. The serial correlation of -0.09 indicates that less than 9.0% of current Newron Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.09 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.94 |
Newron Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Newron Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Newron Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Newron Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Newron Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Newron Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Newron Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Newron Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Newron Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Newron Pharmaceuticals Lagged Returns
When evaluating Newron Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Newron Pharmaceuticals stock have on its future price. Newron Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Newron Pharmaceuticals autocorrelation shows the relationship between Newron Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Newron Pharmaceuticals SpA.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Newron Stock Analysis
When running Newron Pharmaceuticals' price analysis, check to measure Newron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Newron Pharmaceuticals is operating at the current time. Most of Newron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Newron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Newron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Newron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.